Health Condition 1: null- post extraction pain management with transdermal diclofenac diethyleamine and oral diclofenac sodium.
Conditions
Interventions
Intervention1: Diclofenac Diethylamine 100mg: Proprietary name - Nupatch 100,
Manufacturer - Zydus Cadila Healthcare Ltd ,
Formulation - transdermal patch,
Dosage - 100mg,
Frequency and duration - onc
Sponsors
Swaminathan
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient in the age group of 18-55 years will be selected irrespective of sex, caste, religion and socio-economic status. 2. Bilaterally extraction of same teeth in adjacent quadrants of the jaw. 3. Patients who agreed to follow the study protocol.
Exclusion criteria
Exclusion criteria: 1. Uncontrolled systemic diseases. 2. Patient with anti-coagulant therapy. 3. Patient allergic to diclofenac or any NSAIDS 4. Patient under medication of NSAIDS or corticosteroids for any other illness. 5. Patient with history of peptic ulcer. 6. Tender teeth and third molars and periodontally compromised teeth. 7. Uncooperative patients not willing to commit to an appropriate post procedure follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| post operative pain score evaluation in Visual analog scale (0-10) Verbal rating scale (0-3) Pain relief scale (0-3) Pain intensity scale (0-3) Timepoint: post operative pain score is evaluated in post operative 2 hours, 6 hours, 12 hours for three consecutive days.Scoring is stopped when the first emergency medication for pain tablet paracetamol 500mg is consumed by patient.There after number of tablet paracetamol 500mg consumed is calculated. | — |
Secondary
| Measure | Time frame |
|---|---|
| when patient start consuming emergency pain tablets paracetamol500mg, number of tablet paracetamol 500mg consumed is calculated. Timepoint: Number of paracetamol 500mg tablet consumed in a day is noted for three consecutive days. | — |
Countries
India
Contacts
Public ContactDr C Swaminathan
Sree Mookambika Institute of Dental Science
Outcome results
None listed